Dream Big Dreams to Solve Big Problems with Jon Hu, CEO and co-founder of Pepper Bio

Tome Biosciences, a gene editing startup that launched in late 2023 with $213 million in funding, will eliminate 131 positions in November, according to a Worker Adjustment and Retraining Act notice.

The National Science Foundation is funding five projects within its new BioFoundries program, which aims to use artificial intelligence to accelerate research in biosciences.

Greater Boston — particularly Kendall Square in Cambridge and more recently the Seaport District — has become a global leader in the biotech industry over the past decade and a half, but do the hundreds of local layoffs signify a threat to what has become a critical piece of Massachusetts’ economy? Likely not, say industry leaders, rather, they explain that…

In a letter to FDA Commissioner Robert Califf, a House committee flagged several U.S. companies—including Eli Lilly and Pfizer—that have allegedly worked with the People’s Liberation Army on clinical trials in Xinjiang, raising ethical and intellectual property concerns.

The week saw a handful of nine-figure rounds, and biotech got 4 of the top 10 this week. Elektrofi, Navigator Medicines, Noetik, and Butler made the list.